SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 32.29

Change

-0.22 (-0.68)%

Market Cap

N/A

Volume

1.19M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
REGN Regeneron Pharmaceuticals Inc

+8.81 (+0.85%)

USD 126.22B
VRTX Vertex Pharmaceuticals Inc

+1.39 (+0.30%)

USD 120.00B
ALNY Alnylam Pharmaceuticals Inc

+1.84 (+0.67%)

USD 35.01B
ARGX argenx NV ADR

-24.43 (-4.45%)

USD 32.83B
MRNA Moderna Inc

+0.29 (+0.46%)

USD 25.25B
BGNE BeiGene Ltd

+5.81 (+2.81%)

USD 22.45B
SMMT Summit Therapeutics PLC

+0.17 (+0.75%)

USD 17.92B
RPRX Royalty Pharma Plc

+0.54 (+1.95%)

USD 16.34B
UTHR United Therapeutics Corporatio..

-1.79 (-0.50%)

USD 15.71B
PCVX Vaxcyte Inc

-2.02 (-1.78%)

USD 14.50B

ETFs Containing SWTX

BANK:CA Evolve Canadian Banks and.. 12.81 % 0.39 %

+0.05 (+1.11%)

CAD 0.25B
HFIN:CA Hamilton Enhanced Canadia.. 10.32 % 0.00 %

+0.20 (+1.11%)

CAD 0.16B
TQCD:CA TD Q Canadian Dividend ET.. 3.61 % 0.00 %

+0.06 (+1.11%)

CAD 0.38B
TLV:CA Invesco S&P/TSX Composite.. 2.55 % 0.34 %

N/A

CAD 0.09B
CDEF:CA Manulife Smart Defensive .. 2.54 % 0.00 %

+0.03 (+1.11%)

CAD 1.39M
XMD:CA iShares S&P/TSX Completio.. 1.87 % 0.61 %

+0.30 (+1.11%)

CAD 0.22B
CEW:CA iShares Equal Weight Banc.. 0.00 % 0.60 %

+0.13 (+1.11%)

CAD 0.22B
DXM:CA 0.00 % 0.67 %

N/A

N/A
FLI:CA CI U.S. & Canada Lifeco C.. 0.00 % 0.92 %

+0.09 (+1.11%)

CAD 0.09B
HEF:CA 0.00 % 0.83 %

N/A

N/A
HPR:CA Global X Active Preferred.. 0.00 % 0.63 %

+0.03 (+1.11%)

CAD 1.05B
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

N/A

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

+0.52 (+1.11%)

N/A
BNC:CA 0.00 % 0.68 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.53% 55% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.53% 55% F 37% F
Trailing 12 Months  
Capital Gain 37.58% 72% C 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.58% 72% C 79% B-
Trailing 5 Years  
Capital Gain 67.13% 80% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.13% 79% B- 75% C
Average Annual (5 Year Horizon)  
Capital Gain 27.21% 75% C 82% B
Dividend Return 27.21% 75% C 82% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 77.26% 42% F 23% F
Risk Adjusted Return 35.22% 88% B+ 67% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector